PubRank

J LeLorier

Author PubWeight™ 58.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998 4.44
2 Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998 4.15
3 Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997 3.47
4 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 2000 3.31
5 Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med 2001 2.85
6 The risks and costs of multiple-generic substitution of topiramate. Neurology 2009 2.07
7 The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998 1.60
8 Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf 2007 1.44
9 Comparison of efficacy and cost among lipid-lowering agents in patients with primary hypercholesterolemia. Can J Cardiol 1998 1.39
10 Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 2008 1.37
11 Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed". BMJ 2000 1.29
12 Usefulness of probucol in treating primary hypercholesterolemia. Can Med Assoc J 1980 1.27
13 Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 2006 1.22
14 Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999 1.18
15 Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 1997 1.17
16 Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med 1977 1.16
17 Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia. Arch Intern Med 1977 1.14
18 Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study. Clin Invest Med 2001 1.12
19 Predictors of persistence of use of the novel antidiabetic agent acarbose. Arch Intern Med 2001 1.05
20 Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996 1.04
21 Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ 2001 1.04
22 Differences in persistence among different weekly oral bisphosphonate medications. Osteoporos Int 2008 1.02
23 Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum 2000 1.01
24 Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997 0.96
25 Autoinhibition in rabbit aortic strips after epinephrine. J Pharmacol Exp Ther 1967 0.95
26 Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures. Osteoporos Int 2009 0.91
27 Effect of the duration of infusion on the disposition of lidocaine in dogs. J Pharmacol Exp Ther 1977 0.89
28 Exposure to allopurinol and the risk of cataract extraction in elderly patients. Arch Ophthalmol 1998 0.86
29 Estrogen replacement therapy: determinants of persistence with treatment. Obstet Gynecol 2001 0.84
30 Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma. J Clin Epidemiol 1998 0.83
31 Cost of prescribed NSAID-related gastrointestinal adverse events in elderly patients. Br J Clin Pharmacol 2001 0.82
32 Effects of sotalol in twenty patients with cardiac arrhythmias. Int J Clin Pharmacol Biopharm 1977 0.82
33 Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. Am J Obstet Gynecol 1985 0.82
34 Impact of a cost-sharing drug insurance plan on drug utilization among older people. J Am Geriatr Soc 2001 0.82
35 Lidocaine and pentobarbital: a potentially lethal drug-drug interaction. Toxicol Appl Pharmacol 1978 0.80
36 Pharmacoeconomics and health policy. Current applications and prospects for the future. Pharmacoeconomics 1999 0.80
37 Potentiation of lidocaine toxicity by pentobarbital in the dog. Toxicol Appl Pharmacol 1979 0.79
38 Incontinence drug utilization patterns in Québec, Canada. Value Health 2006 0.78
39 Long-term survival and functional status in the elderly after cardiac surgery. Can J Cardiol 1997 0.78
40 Uptake of and response to norepinephrine by certain tissues of hypertensive rats. Am J Physiol 1976 0.78
41 Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDs. Pharmacoeconomics 2001 0.77
42 Patterns of amlodipine and felodipine use in an elderly Quebec population. Can J Cardiol 2000 0.77
43 Experience with probucol in the treatment of hypercholesterolemia. Artery 1982 0.76
44 Effect of nitroglycerin on regional myocardial blood flow following an experimental coronary spasm. Angiology 1984 0.76
45 Gastrointestinal damage associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1992 0.75
46 Comparing results from meta-analyses vs large trials. JAMA 1998 0.75
47 The effects of propranolol, practolol, and placebo on the clinical manifestations of thyrotoxicosis. Int J Clin Pharmacol Biopharm 1976 0.75
48 Uptake of norepinephrine as a determinant of the magnitude of the inotropic response. Proc Soc Exp Biol Med 1969 0.75